1-14 of 14
Oliver Sartor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer

Pradeep S. Chauhan, Irfan Alahi, Savar Sinha, Elisa M. Ledet, Ryan Mueller, Jessica Linford, Alexander L. Shiang, Jace Webster, Lilli Greiner, Breanna Yang, Gabris Ni, Ha X. Dang, Debanjan Saha, Ramandeep K. Babbra, Wenjia Feng, Peter K. Harris, Faridi Qaium, Dzifa Y. Duose, Sanchez E. Alexander, Alexander D. Sherry, Ellen B. Jaeger, Patrick J. Miller, Sydney A. Caputo, Jacob J. Orme, Fabrice Lucien, Sean S. Park, Chad Tang, Russell K. Pachynski, Oliver Sartor, Christopher A. Maher, Aadel A. Chaudhuri
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (1): 151–163.
https://doi.org/10.1158/1078-0432.CCR-24-1658
Published: 06 January 2025
View article titled, Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
Open the PDF for Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Structurally-oriented classification of FOXA1 alterations identifies prostate cancers with opposing clinical outcomes and distinct molecular and immunologic subtypes

Justin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J. Kwon, Eamon Toye, David Moline, Mark G. Evans, Andrew Elliott, Rachel Passow, Christine Luo, Emily John, Nishant Gandhi, Rana R. McKay, Elisabeth I. Heath, Chadi Nabhan, Natalie Reizine, Jacob J. Orme, Josep M. Domingo Domenech, Oliver Sartor, Sylvan C. Baca, Scott M. Dehm, Emmanuel S. Antonarakis
Journal: Clinical Cancer Research
Clin Cancer Res (2025)
https://doi.org/10.1158/1078-0432.CCR-24-3471
Published: 02 January 2025
View article titled, Structurally-oriented classification of <em>FOXA1</em> alterations identifies prostate cancers with opposing clinical outcomes and distinct molecular and immunologic subtypes
Open the PDF for Structurally-oriented classification of <em>FOXA1</em> alterations identifies prostate cancers with opposing clinical outcomes and distinct molecular and immunologic subtypes in another window
Includes: Supplementary data
Journal Articles

Circulating Tumor DNA Biomarkers for Response Assessment in Prostate Cancer

Oliver Sartor
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (15): 2745–2747.
https://doi.org/10.1158/1078-0432.CCR-23-1043
Published: 01 August 2023
View article titled, Circulating Tumor DNA Biomarkers for Response Assessment in Prostate Cancer
Open the PDF for Circulating Tumor DNA Biomarkers for Response Assessment in Prostate Cancer in another window
Journal Articles

Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer

Zachary Quinn, Benjamin Leiby, Guru Sonpavde, Atish D. Choudhury, Christopher Sweeney, David Einstein, Russell Szmulewitz, Oliver Sartor, Karen Knudsen, Eddy Shih-Hsin Yang, Wm. Kevin Kelly
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (1): 50–59.
https://doi.org/10.1158/1078-0432.CCR-22-2526
Published: 04 January 2023
View article titled, Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
Open the PDF for Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate Cancer

Lawrence Fong, Michael J. Morris, Oliver Sartor, Celestia S. Higano, Lance Pagliaro, Ajjai Alva, Leonard J. Appleman, Winston Tan, Ulka Vaishampayan, Raphaelle Porcu, Darren Tayama, Edward E. Kadel, III, Kobe C. Yuen, Asim Datye, Andrew J. Armstrong, Daniel P. Petrylak
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (17): 4746–4756.
https://doi.org/10.1158/1078-0432.CCR-21-0063
Published: 01 September 2021
View article titled, A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate Cancer
Open the PDF for A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PO-077: Study evaluating metastatic castrate resistant prostate cancer (mCRPC) treatment using 177Lu-PNT2002 PSMA therapy after second-line hormonal treatment (SPLASH) - Trial in progress

Kim N. Chi, Ur Metser, Johannes Czernin, Jeremie Calais, Vikas Prasad, Matthias Eiber, Neal Shore, Jessica Jensen, Neil Fleshner, Scott Tagawa, Oliver Sartor
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-077.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-077
Published: 15 April 2021
View article titled, Abstract PO-077: Study evaluating metastatic castrate resistant prostate cancer (mCRPC) treatment using <sup>177</sup>Lu-PNT2002 PSMA therapy after second-line hormonal treatment (SPLASH) - Trial in progress
Journal Articles

Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

Catherine H. Marshall, Wei Fu, Hao Wang, Jong Chul Park, Theodore L. DeWeese, Phuoc T. Tran, Daniel Y. Song, Serina King, Michaella Afful, Julia Hurrelbrink, Charlotte Manogue, Patrick Cotogno, Nancy P. Moldawer, Pedro C. Barata, Charles G. Drake, Edwin M. Posadas, Andrew J. Armstrong, Oliver Sartor, Emmanuel S. Antonarakis
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (6): 1623–1630.
https://doi.org/10.1158/1078-0432.CCR-20-4476
Published: 15 March 2021
View article titled, Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer
Open the PDF for Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors

Neelima Vidula, Thereasa A. Rich, Oliver Sartor, Jennifer Yen, Aaron Hardin, Tracy Nance, Michael B. Lilly, Mohammad Amin Nezami, Sandip P. Patel, Benedito A. Carneiro, Alice C. Fan, Adam M. Brufsky, Barbara A. Parker, Benjamin B. Bridges, Neeraj Agarwal, Benjamin L. Maughan, Victoria M. Raymond, Stephen R. Fairclough, Richard B. Lanman, Aditya Bardia, Massimo Cristofanilli
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2546–2555.
https://doi.org/10.1158/1078-0432.CCR-19-2933
Published: 01 June 2020
View article titled, Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion <em>BRCA</em> Mutations among Patients with Advanced Solid Tumors
Open the PDF for Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion <em>BRCA</em> Mutations among Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer

Fangfang Qu, Wanling Xie, Mari Nakabayashi, Haitao Zhang, Seong Ho Jeong, Xiaodong Wang, Kazumasa Komura, Christopher J. Sweeney, Oliver Sartor, Gwo-Shu Mary Lee, Philip W. Kantoff
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (3): 726–734.
https://doi.org/10.1158/1078-0432.CCR-16-1070
Published: 31 January 2017
View article titled, Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer
Open the PDF for Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells

Shahriar Koochekpour, Sunipa Majumdar, Gissou Azabdaftari, Kristopher Attwood, Ray Scioneaux, Dhatchayini Subramani, Charles Manhardt, Giovanni D. Lorusso, Stacey S. Willard, Hillary Thompson, Mojgan Shourideh, Katayoon Rezaei, Oliver Sartor, James L. Mohler, Robert L. Vessella
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (21): 5888–5901.
https://doi.org/10.1158/1078-0432.CCR-12-1308
Published: 06 November 2012
View article titled, Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells
Open the PDF for Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Overcoming Chemotherapy Resistance in Prostate Cancer

Ravi A. Madan, Sumanta Kumar Pal, Oliver Sartor, William L. Dahut
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 3892–3902.
https://doi.org/10.1158/1078-0432.CCR-10-2654
Published: 15 June 2011
View article titled, Overcoming Chemotherapy Resistance in Prostate Cancer
Open the PDF for Overcoming Chemotherapy Resistance in Prostate Cancer in another window
Journal Articles

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

Mary-Ellen Taplin, Meredith M. Regan, Yoo-Joung Ko, Glenn J. Bubley, Stephen E. Duggan, Lillian Werner, Tomasz M. Beer, Christopher W. Ryan, Paul Mathew, Shi-Ming Tu, Samuel R. Denmeade, William K. Oh, Oliver Sartor, Christos S. Mantzoros, Roger Rittmaster, Philip W. Kantoff, Steven P. Balk
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 7099–7105.
https://doi.org/10.1158/1078-0432.CCR-09-1722
Published: 11 November 2009
View article titled, Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer
Open the PDF for Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer in another window
Journal Articles

Quality of Reporting of Serious Adverse Drug Events to an Institutional Review Board: A Case Study with the Novel Cancer Agent, Imatinib Mesylate

David A. Dorr, Rachel Burdon, Dennis P. West, Jennifer Lagman, Christina Georgopoulos, Steven M. Belknap, June M. McKoy, Benjamin Djulbegovic, Beatrice J. Edwards, Sigmund A. Weitzman, Simone Boyle, Martin S. Tallman, Moshe Talpaz, Oliver Sartor, Charles L. Bennett
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (11): 3850–3855.
https://doi.org/10.1158/1078-0432.CCR-08-1811
Published: 01 June 2009
View article titled, Quality of Reporting of Serious Adverse Drug Events to an Institutional Review Board: A Case Study with the Novel Cancer Agent, Imatinib Mesylate
Open the PDF for Quality of Reporting of Serious Adverse Drug Events to an Institutional Review Board: A Case Study with the Novel Cancer Agent, Imatinib Mesylate in another window
Includes: Supplementary data
Journal Articles

Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality

Kathryn L. Penney, Claudia A. Salinas, Mark Pomerantz, Fredrick R. Schumacher, Christine A. Beckwith, Gwo-Shu Lee, William K. Oh, Oliver Sartor, Elaine A. Ostrander, Tobias Kurth, Jing Ma, Lorelei Mucci, Janet L. Stanford, Philip W. Kantoff, David J. Hunter, Meir J. Stampfer, Matthew L. Freedman
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (9): 3223–3230.
https://doi.org/10.1158/1078-0432.CCR-08-2733
Published: 30 April 2009
View article titled, Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality
Open the PDF for Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality in another window
Includes: Supplementary data